Your browser doesn't support javascript.
loading
Sonographic Features Differentiating Follicular Thyroid Cancer from Follicular Adenoma-A Meta-Analysis.
Borowczyk, Martyna; Wolinski, Kosma; Wieckowska, Barbara; Jodlowska-Siewert, Elzbieta; Szczepanek-Parulska, Ewelina; Verburg, Frederik A; Ruchala, Marek.
Affiliation
  • Borowczyk M; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
  • Wolinski K; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
  • Wieckowska B; Department of Computer Science and Statistics, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
  • Jodlowska-Siewert E; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
  • Szczepanek-Parulska E; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
  • Verburg FA; Department of Radiology and Nuclear Medicine, Erasmus MC, 3015 Rotterdam, The Netherlands.
  • Ruchala M; Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 61-701 Poznan, Poland.
Cancers (Basel) ; 13(5)2021 Feb 24.
Article in En | MEDLINE | ID: mdl-33668130
Certain ultrasound features are associated with an increased risk of thyroid malignancy. However, they were studied mainly in papillary thyroid cancers (PTCs); these results cannot be simply extrapolated for the differentiation of follicular thyroid adenomas and cancers (FTAs and FTCs). The aim of our study was to perform a meta-analysis to identify sonographic features suggesting malignancy in the case of follicular lesions, potentially differentiating FTA and FTC. We searched thirteen databases from January 2006 to December 2020 to find all relevant, full-text journal articles written in English. Analyses assessed the accuracy of malignancy detection in case of follicular lesions, potentially differentiating FTA and FTC included the odds ratio (OR), sensitivity, specificity, positive and negative predictive values. A random-effects model was used to summarize collected data. Twenty studies describing sonographic features of 10,215 nodules met the inclusion criteria. The highest overall ORs to increase the risk of malignancy were calculated for tumor protrusion (OR = 10.19; 95% confidence interval: 2.62-39.71), microcalcifications or mixed type of calcifications (coexisting micro and macrocalcifications): 6.09 (3.22-11.50), irregular margins: 5.11 (2.90-8.99), marked hypoechogenicity: 4.59 (3.23-6.54), and irregular shape: 3.6 (1.19-10.92). The most crucial feature associated with an increased risk of FTC is capsule protrusion, followed by the presence of calcifications, irrespectively of their type.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Systematic_reviews Language: En Journal: Cancers (Basel) Year: 2021 Document type: Article Affiliation country: Poland Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Systematic_reviews Language: En Journal: Cancers (Basel) Year: 2021 Document type: Article Affiliation country: Poland Country of publication: Switzerland